Results 121 to 130 of about 2,566,374 (138)
Correction to: Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]
Rheumatology (Oxford)europepmc +1 more source
Treatment approaches and adherence to urate-lowering therapy for patients with gout [PDF]
Patient Preference and Adherence, 2017 Thanda Aung,* Gihyun Myung,* John D FitzGerald Division of Rheumatology/Department of Internal Medicine, University of California, Los Angeles, Los Angeles, CA, USA *These authors contributed equally to this work Abstract: Gout is the most common ...
John Fitzgerald, Thanda Aung
exaly +5 more sources
Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
Seminars in Arthritis and Rheumatism, 2017 Objective The observed associations of hyperuricaemia with hypertension, cardiovascular disease and kidney disease are receiving increasing interest. The potential role of urate-lowering therapy in the management of these “non-gout diseases” has been ...
Lisa Stamp, Nicola Dalbeth
exaly +2 more sources
Journal of NephrologyInternational audienceBackground: Hyperuricemia is a hallmark of gout and a suspected risk factor for the progression of chronic kidney disease (CKD). However, the impact of urate-lowering therapy on CKD progression is subject to debate. The objective of
Sophie Liabeuf +2 more
exaly +2 more sources
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review [PDF]
International Journal of Pharmacy Practice, 2022 The aim of this study was to systematically review and compare the quantitative effect of clinical interventions designed to improve adherence to urate-lowering therapy.
Dyfrig A. Hughes +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: